Lee Health develops Enzymeact to treat digestive disorders

City-based pharmaceutical company Lee Health Domain has developed a unique pancreatic enzyme blend called Enzymeact, derived from a vegetarian source to support pancreatic exocrine insufficiency.


City-based pharmaceutical company Lee Health Domain has developed a unique pancreatic enzyme blend called Enzymeact, derived from vegetarian source to support pancreatic exocrine insufficiency. The capsule contains amylase, protease and lipase which are derived from vegetarian source by microbial fermentation technology. Amylase aids in digestion by breaking down carbohydrates, protease helps in the digestion of dietary proteins to allow absorption of amino acids and lipase breaks down fats in food to help better absorption in the intestine.



https://www.bizzbuzz.news/industry/pharma/lee-health-develops-enzymeact-to-treat-digestive-disorders-1070853

9 views0 comments